Clinical Trial Tests Therapy for EGFR-Mutant Lung Cancer
Dr. Elaine Shum, a medical oncologist at NYU Langone’s Perlmutter Cancer Center, leads a clinical trial for people with advanced lung cancer.
Clinical Trial to Study Antibody Treatment Against COVID-19
NYU Langone researchers are testing whether an antibody therapy can safely reduce 2019 coronavirus disease (COVID-19) severity.
Clinical Trials Advance Cancer Care
NYU Langone’s Perlmutter Cancer Center is leading the way in providing clinical trials for people with cancer on Long Island.
Clinical Trials Explore New Prostate Cancer Therapies
Researchers at NYU Langone’s Perlmutter Cancer Center are investigating two new treatments for prostate cancer.
Clinical Trials Explore New Treatment for Gynecologic Cancer
Clinical trials at NYU Langone’s Perlmutter Cancer Center are testing antibody–drug conjugates as a treatment for gynecologic cancers.
Clinical Trials Focus on Lung Tumor Immunotherapy Response
NYU Langone pulmonologist Dr. Daniel H. Sterman leads new study to boost lung tumor response rate to immunotherapy.
Clinical Trials Important to Cancer Research
Dr. Benjamin G. Neel, director of NYU Langone’s Perlmutter Cancer Center, explains how clinical trials help advance treatment options.
Clinical Trials Led to FDA-Approved Cancer Drugs in 2021
Clinical trials at NYU Langone’s Perlmutter Cancer Center played a role in new drugs approved in 2021 for people with cancer.
Clinical Trials Office: 2024 PRMC Full Board Review Schedule
Clinical Trials Office 2024 PRMC Full Board Review Schedule PRMC Meeting Dates Submission Deadline (1 ...
Clinical Trials Test Targeted Breast Cancer Treatments
Dr. Nancy Chan, a medical oncologist at NYU Langone’s Perlmutter Cancer Center, leads two clinical trials of targeted breast cancer treatment.
